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Identification and Mechanism of Action of Two
Histidine Residues Underlying High-Affinity
Zn21 Inhibition of the NMDA Receptor
Westbrook, 1990). The cloning of cDNAs encoding
NMDA receptor (NMDAR) subunits (Moriyoshi et al.,
1991; Kutsuwada et al., 1992; Meguro et al., 1992; Mon-
yer et al., 1992; Ishii et al., 1993) affords us the opportu-
nity to investigate the molecular basis of Zn21 inhibition
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of recombinant NMDA receptors. Recombinant NR1/Harvard Medical School
NR2A and NR1/NR2B receptors exhibit similar voltage-Boston, Massachusetts 02115
dependent block, but voltage-independent inhibition
occurs with much higher apparent affinity for NR1/NR2A
than NR1/NR2B receptors (nanomolar versus micromo-Summary
lar IC50, respectively) (Williams, 1996; Chen et al., 1997;
Paoletti et al., 1997). Moreover, under standard re-Zinc (Zn21) inhibition of N-methyl-D-aspartate receptor
cording conditions, tonic inhibition by endogenous Zn21(NMDAR) activity involves both voltage-independent
of NMDA receptors containing NR2A subunits may oc-and voltage-dependent components. Recombinant
cur based on the observation that heavy metal chelatorsNR1/NR2A and NR1/NR2B receptors exhibit similar
potentiate NMDA-evoked currents (Paoletti et al., 1997).voltage-dependent block, but voltage-independent
The NR1 splice variant containing exon 5 (NR1±1b) wasZn21 inhibition occurs with much higher affinity for
shown to increase the IC50 for voltage-independent Zn21NR1/NR2A than NR1/NR2B receptors (nanomolar ver-
inhibition 3- to 10-fold compared with the NR1 splicesus micromolar IC50, respectively). Here, we show that
variant lacking exon 5 (NR1±1a) when expressed astwo neighboring histidine residues on NR2A represent
NR1/NR2A or NR1/NR2B receptors (Paoletti et al., 1997;the critical determinant (termed the ªshort spacerº)
Traynelis et al., 1998). The same basic amino acid resi-for high-affinity, voltage-independent Zn21 inhibition
dues within exon 5 that control proton inhibition alsousing the Xenopus oocyte expression system and site-
appear to control the effects of exon 5 on Zn21 inhibition;directed mutagenesis. Mutation of either one of these
this observation led to the suggestion that Zn21 andtwo histidine residues (H42 and H44) in the extracellu-
proton inhibition may share common structural determi-lar N-terminal domain of NR2A shifted the IC50 for high- nants (Traynelis et al., 1998). The present study showsaffinity Zn21 inhibition z200-fold without affecting the
a much more profound effect of NR2A mutations onEC50 of the coagonists NMDA and glycine. We suggest high-affinity, voltage-independent Zn21 inhibition andthat the mechanism of high-affinity Zn21 inhibition on
suggests for the first time that the mechanism of inhibi-the NMDAR involves enhancement of proton inhi-
tion of high-affinity Zn21 binding to NR1±1a/NR2A recep-
bition.
tors may involve the enhancement of proton inhibition.
Based on enzymatic studies, Zn21 binding sites are
typically formed by four to six ligands, involving mostIntroduction
frequently histidine, cysteine, aspartate, or glutamate
residues (Vallee and Falchuk, 1993). A single histidineZinc (Zn21) is an abundant cation in excitatory terminals
residue has been identified as essential for Zn21 inhibi-in the hippocampus and is released into the synaptic
tion of GABA r1 receptors (Wang et al., 1995), and more
cleft during neurotransmission, reaching concentrations
recently, it was shown that histidine residues on the b
up to 300 mM (Assaf and Chung, 1984; Howell et al.,
(Wooltorton et al., 1997; Horenstein and Akabas, 1998)
1984; Xie and Smart, 1991). Thus, the action of Zn21 in and and a6 (Fisher and Macdonald, 1998) subunits of
the central nervous system is thought to have major GABAA receptors mediate subunit-specific differencesphysiological significance. In support of this idea, Zn21 in Zn21 inhibition. Heretofore, however, amino acid resi-
has been shown to inhibit currents mediated by the dues involved in high-affinity Zn21 binding to NMDA re-
NMDA subtype of glutamate receptor (Peters et al., ceptors have not been identified. Here, we report that
1987; Westbrook and Mayer, 1987) and by the GABAA H42 and H44 of the NR2A subunit represent the major
subtype of g-aminobutyric acid receptor (Westbrook molecular determinant for high-affinity, voltage-inde-
and Mayer, 1987). In addition, excessive extracellular pendent Zn21 inhibition of recombinant NR1±1a/NR2A
Zn21 may play an important role in excitotoxicity during receptors. In studies analyzing the stability of Zn21 bind-
cerebral ischemia (Koh and Choi, 1988; Koh et al., 1996). ing sites on other proteins (Vallee and Falchuk, 1993),
Zn21 antagonizes NMDA responses via a dual mecha- similar histidine residues have been designated the
nism involving both voltage-independent and voltage- ªshort spacer,º forming a bidentate Zn21 complex, and
dependent inhibition. Voltage-independent Zn21 inhibi- represent the major residues that bind Zn21.
tion is manifest by a decreased frequency of channel
opening, while voltage-dependent inhibition involves Results
channel block resembling that produced by Mg21 (Mayer
et al., 1989; Christine and Choi, 1990; Legendre and The Histidine-Modifying Agent Diethyl Pyrocarbonate
Blocks Zn21 Inhibition of NR1±1a/NR2A Receptors
NMDA-evoked whole-cell currents were recorded at* To whom correspondence should be addressed (e-mail: slipton@
rics.bwh.harvard.edu). 280 mV in Xenopus oocytes expressing recombinant
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Figure 1. Block of Zn21 Inhibition of NMDA
Receptors by the Histidine-Modifying Agent
DEPC but Not by the Amino Group±Modifying
Agent TNBS
(A) Potentiation of NMDA-evoked currents
(200 mM NMDA plus 100 mM glycine) by the
heavy metal chelator tricine (10 mM) in an
oocyte expressing NR1±1a/NR2A receptors
before and after DEPC application (3 mM).
Currents were recorded at a holding potential
of 280 mV at pH 7.3. Tricine potentiated
NMDA-evoked currents in NR1±1a/NR2A re-
ceptors by removing trace amounts of Zn21.
Following sequential treatment with 3 mM
DEPC and 10 mM tricine for 2 min, and then
DEPC alone for 1 min, tricine potentiation of
NR1±1a/NR2A receptor responses was virtu-
ally abolished. Tricine potentiation of NR1±1a/
NR2A receptor activity is expressed as a per-
centage of the response to NMDA in un-
treated oocytes (mean 6 SEM, n 5 4 for each
condition). Tricine potentiation after DEPC
treatment was significantly different from the
pre-DEPC responses (asterisk, p , 0.01;
paired t tests for the same oocytes). When 10
mM Zn21 was coapplied with DEPC, allowing
them to compete, the effect of DEPC on tri-
cine potentiation was decreased compared
with the absence of Zn21 during DEPC incu-
bation (dagger, p , 0.01 by unpaired t test
comparing the absence versus presence of
Zn21 during DEPC treatment).
(B) Representative current tracings from oo-
cytes expressing NR1±1a/NR2A before and
after DEPC treatment. Various concentra-
tions of Zn21 were applied in the presence of
saturating concentrations of NMDA (200 mM)
plus glycine (100 mM). Zn21 concentrations
#1 mM correspond to free [Zn21] in solutions
buffered with 10 mM tricine (see Experimental
Procedures). Currents were recorded at a
holding potential of 240 mV at pH 7.3. Top
trace, pre-DEPC treatment with nanomolar
concentrations of Zn21; middle trace, post-
DEPC treatment with nanomolar concentra-
tions of Zn21; bottom trace, post-DEPC treat-
ment with micromolar concentrations of Zn21.
(C) Zn21 inhibition curves for NR1±1a/NR2A
receptors before DEPC treatment (closed cir-
cles), after DEPC treatment (open circles),
and after TNBS treatment (open squares).
NMDA-evoked currents are expressed as a percentage of the current recorded in the presence of the Zn21 chelator tricine (10 mM). Each
point represents the mean 6 SEM of the responses obtained from four oocytes.
(D) I±V relationship for oocytes expressing NR1±1a/NR2A receptors before (top) and after (bottom) DEPC treatment at various Zn21 concentra-
tions. The ª0º Zn21 solution contained 10 mM tricine and was therefore nominally Zn21 free. I±V curves were generated by continuously
ramping the voltage, as described in the Experimental Procedures section. This experiment was repeated in four oocytes with similar results.
(E) NMDA dose±response curves in the presence of a saturating concentration of glycine (100 mM).
(F) Glycine dose±response curves in the presence of a saturating concentration of NMDA (200 mM).
For (E) and (F), the responses of NR1±1a/NR2A receptors were measured before (closed circles) and after (open circles) DEPC treatment.
EC50 values were calculated from dose±response curves generated by fitting the data with the equation:
I 5 Imax/{1 1 (EC50/[agonist])n}
where n is the Hill slope and Imax is the maximum response normalized to 100%. Each point represents the mean 6 SEM of the responses
obtained from four oocytes.
NR1±1a/NR2A receptors (see Experimental Procedures NR1±1a/NR2A receptors. However, following sequential
exposure to tricine and diethyl pyrocarbonate (DEPC)for the nomenclature of NR1 splice variants). As Paoletti
et al. (1997) have shown previously, the heavy metal for 2 min (to chelate endogenous Zn21 and thus allow
DEPC access to histidine residues that might be coordi-chelating agent, tricine (10 mM), potentiated NMDA-
evoked currents (Figure 1A). This result suggested that nating Zn21), followed by DEPC alone for 1 min, tricine
potentiation and Zn21 inhibition were virtually abrogatedtrace amounts of a heavy metal (probably Zn21) contami-
nate standard recording solutions and tonically inhibit (tricine potentiation: 106% 6 1%, post-DEPC treatment,
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versus 182% 6 12%, pre-DEPC treatment; n 5 4) (Figure
1A). When 10 mM Zn21 was included during the incuba-
tion in 3 mM DEPC, the effect of DEPC was decreased
compared with that observed in the absence of Zn21
(tricine potentiation: 175% 6 10%, n 5 4) (Figure 1A).
To demonstrate that high-affinity Zn21 inhibition was
indeed abolished by the DEPC modification of histidine
residues, we constructed Zn21 dose±response curves
for NR1±1a/NR2A receptors before and after DEPC
treatment (Figures 1B and 1C). Voltage-independent
Zn21 inhibition of NR1±1a/NR2A receptors occurs at low
Zn21 concentrations, with an IC50 in the nanomolar range
(Williams, 1996; Chen et al., 1997; Paoletti et al., 1997),
and the estimated Zn21 contamination in recording solu- Figure 2. Schematic Representation of an NMDAR Subunit and
Comparison of Aligned Sequences Containing Histidine Residuestions is z10±300 nM (Paoletti et al., 1997; Zheng et al.,
in Close Approximation1998). Therefore, to precisely control the concentration
The positions of NR2A histidine residues mutated in this study areof Zn21, we carried out the dose±response experiments
shown in the context of the proposed transmembrane topology ofin tricine-buffered solutions for [Zn21] #1 mM: ª0º Zn21
NMDAR subunits with an extracellular N terminus, an intracellularrefers to a nominally ªZn21-freeº solution with 10 mM
C terminus, three transmembrane domains (M1, M3, and M4), and
tricine and no added Zn21; the other listed [Zn21] #1 mM an M2 domain forming a reentrant loop (Wo and Oswald, 1994;
correspond to estimated free [Zn21] in tricine-buffered Hollmann et al., 1994; Wood et al., 1995).
solutions, calculated as detailed in the Experimental Pro-
cedures section. At 240 mV, the Zn21 dose±response
curve for NR1±1a/NR2A receptors was well fit with a EC50 for NMDA after DEPC treatment was 44.7 6 1.8
two binding site isotherm, yielding IC50 values of 5.2 6 mM compared with 31.8 6 2.1 before DEPC treatment
0.7 nM and 78 6 37 mM (with relative weights of 61% (Figure 1E); the EC50 for glycine after DEPC treatment
and 39%, representing voltage-independent and volt- was 0.84 6 0.05 mM compared with 3.2 6 0.1 mM before
age-dependent inhibition, respectively) (Figures 1B, top DEPC treatment (Figure 1F). It appears, therefore, that
trace, and 1C). In contrast, the Zn21 dose±response the agonist binding sites of the NMDA receptor are not
curve after DEPC could be fit with a single binding site much affected by DEPC treatment.
isotherm yielding an IC50 value of 62 6 3.3 mM and a Hill
coefficient of 0.88 6 0.04 (Figures 1B, middle and bottom
Two Histidine Residues in NR2A Underlie
traces, and 1C).
the High-Affinity Zn21 Effect on
As previously reported (Williams, 1996; Chen et al.,
NR1±1a/NR2A Receptors
1997; Paoletti et al., 1997), current±voltage (I±V) curves
The results from the experiments with DEPC suggested
for NR1±1a/NR2A receptors exhibit voltage-dependent
that histidine residue(s) may constitute the critical com-inhibition at [Zn21] .1 mM (Figure 1D, top trace). To
ponent of the binding site mediating high-affinity Zn21test whether the component of Zn21 inhibition remaining
inhibition of NR1±1a/NR2A receptors. Given that high-after DEPC treatment (and observed only at [Zn21] .1
affinity, voltage-independent Zn21 inhibition occurs in
mM) represented voltage-dependent block, we recorded
NR1±1a/NR2A but not NR1±1a/NR2B receptors (Wil-NMDA-evoked currents at different concentrations of
liams, 1996; Chen et al., 1997; Paoletti et al., 1997), weZn21 while ramping the voltage from 2100 to 150 mV.
reasoned that amino acid residues responsible for thisZn21 inhibition was only apparent at hyperpolarizing po-
high-affinity component of inhibition may be unique totentials (Figure 1D, bottom trace), indicating that only
the NR2A subunit. In general, it has been observed forlow-affinity, voltage-dependent Zn21 block remained
Zn21 binding sites that the first amino acid ligand in theafter DEPC exposure.
primary protein sequence is nearly always separatedSince DEPC is not completely specific for the imidaz-
from the second ligand by one, two, or three amino acidole group of histidine residues and may also react with
residues (Vallee and Falchuk, 1993). Inspection of theamino groups, we performed a series of control experi-
predicted amino acid sequence of NMDA receptor sub-ments with trinitrobenzenesulfonic acid (TNBS), which
units revealed two pairs of histidines that are unique tointeracts specifically with amino groups (Means and
NR2A and separated by three or fewer residues: H42Feeney, 1971; Holmgren et al., 1998). Unlike DEPC, treat-
and H44, and H332 and H335 (Figure 2). We thus mutatedment with TNBS (3 mM 3 3 min [pH 9.0]) did not block
each of these histidine residues, singly and in pairs,high-affinity Zn21 inhibition (Figure 1C), although it did
and expressed the NR2A mutant subunits with wild-typeslow activation and deactivation kinetics somewhat.
NR1±1a in oocytes. Initially, to make the most conserva-Taken together, the data suggest that the modification
tive change, we mutated histidine to tyrosine. If the mu-of histidine residues with DEPC blocks the high-affinity,
tation of a particular histidine residue affected the de-voltage-independent component of Zn21 inhibition of
gree of potentiation by tricine, then that histidine wasNR1±1a/NR2A receptors, possibly by competing with
subsequently mutated to the amino acid residue thatZn21 for the same (histidine) sites.
occupied the homologous position in NR2B in order toTo rule out the possibility that modifying histidine resi-
produce a ªknock-inº mutant. Potentiation of NMDA-dues with DEPC produced extensive structural changes
evoked currents by 10 mM tricine was used as a meansaffecting NMDA receptor properties, we constructed
to screen for high-affinity Zn21 inhibition. The degreeNMDA and glycine dose±response curves for NR1±1a/
NR2A receptors before and after DEPC treatment. The of tricine potentiation of NMDA-evoked currents in
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Figure 3. Effect of NR2A Histidine Mutants
on Tricine Potentiation
(A) Current tracings showing similar potentia-
tion of NMDA-evoked (200 mM NMDA plus
100 mM glycine) currents by tricine (10 mM) in
oocytes expressing wild-type NR1±1a/NR2A
and mutant NR1±1a/NR2A(H332Y,H335Y) re-
ceptors. In contrast, tricine did not potentiate
NMDA responses in oocytes expressing
NR1±1a/NR2A(H42G,H44S), NR1±1a/NR2A
(H42T,H44D), or NR1±1a/NR2B receptors.
The degree of potentiation by tricine of
NMDA-evoked currents in NR1±1a/NR2A/
NR2B receptors was between that of NR1±1a/
NR2A receptors and NR1±1a/NR2B recep-
tors. Tricine potentiation was virtually elimi-
nated in NR1±1a/NR2A(H42G,H44S)/NR2B
receptors.
(B) Potentiation of NMDA-evoked currents by tricine (mean 6 SEM, n 5 4±6 for each group) in wild-type or mutant NR1±1a/NR2A receptors
expressed as a percentage of the response to NMDA in the absence of tricine. The dotted line represents NMDA responses that are not
potentiated by tricine (hence, are the same as the pretricine level). Tricine potentiation of NR1±1a/NR2A(H42G,H44S), NR1±1a/
NR2A(H42T,H44D), NR1±1a/NR2B, NR1±1a/NR2A/NR2B, and NR1±1a/NR2A(H42G,H44S)/NR2B receptor responses was significantly less than
that of wild-type NR1±1a/NR2A or NR1±1a/NR2A(H332Y,H335Y) receptors (asterisk, p , 0.001; ANOVA followed by Fisher's protected least
significant difference test).
NR1±1a/NR2A(H332Y,H335Y) receptors (203% 6 9%, and 4B). We again carried out the dose±response experi-
ments in tricine-buffered solutions as described above.n 5 5) was indistinguishable from that of wild-type
NR1±1a/NR2A receptors (200% 6 10%, n 5 4). In con- At 240 mV, the Zn21 dose±response curve for NR1±1a/
NR2A receptors was well fit with a two binding sitetrast, there was no discernible potentiation by tricine of
NR1±1a/NR2A(H42G,H44S) receptors (99% 6 1%, n 5 isotherm as shown in Figure 1B. In contrast, the Zn21
dose±response curve for NR1±1a/NR2A(H42G,H44S) re-6) or NR1±1a/NR2A(H42T,H44D) receptors (101% 6 1%,
n 5 4). Additionally, as expected, there was very little ceptors could be fit with a single binding site isotherm,
yielding an IC50 value of 2.8 6 0.3 mM and a Hill coefficientpotentiation in NR1±1a/NR2B receptors (108% 6 2%,
n 5 5; Figures 3A and 3B). These results indicate that of 0.77 6 0.06. Similarly, the Zn21 dose±response curve
for NR1±1a/NR2A(H42T,H44D) receptors yielded an IC50the mutation of NR2A H42 and/or H44 abrogated the
inhibition caused by trace amounts of Zn21 in wild-type value of 3.0 6 0.5 mM and a Hill coefficient of 0.67 6 0.07.
Moreover, the Zn21 dose±response curves for NR1±1a/NR1±1a/NR2A receptors.
By biochemical criteria, the predominant NMDA re- NR2A receptors bearing a single histidine mutant re-
vealed that mutating either one of the NR2A(H42,H44)ceptor±channel complex in vivo contains at least three
subunits, NR1, NR2A, and NR2B (Sheng et al., 1994; histidine pair was sufficient to cause approximately the
same shift in IC50 (Figure 4B). For example, the Zn21Luo et al., 1997). Additionally, when NR1 and two types
of NR2 subunits were injected into Xenopus oocytes, dose±response curve for NR1±1a/NR2A(H42G) recep-
tors displayed an IC50 of 1.1 6 0.1 mM and a Hill coeffi-heteromers composed of all three subunits were the
predominant form (Wafford et al., 1993). Thus, we tested cient of 0.76 6 0.06, and the Zn21 dose±response curve
for NR1±1a/NR2A(H44S) receptors had an IC50 of 2.1 6whether mutating H42 and H44 of NR2A would abolish
the inhibition caused by trace amounts of Zn21 in recep- 0.2 mM and a Hill coefficient of 0.70 6 0.04.
The remaining inhibition of NR1±1a/NR2A(H42G,H44S)tors made up of NR1±1a/NR2A/NR2B subunits. Tricine
potentiation of NMDA-evoked currents of wild-type receptor responses seen at higher Zn21 concentrations
(Figure 4A, lower trace) could have been due to eitherNR1±1a/NR2A/NR2B receptors was between that of
NR1±1a/NR2A and NR1±1a/NR2B receptors (147% 6 voltage-dependent block or a shift in the IC50 for voltage-
independent Zn21 inhibition, resulting in overlap of the10%, n 5 5; Figures 3A and 3B). In contrast, tricine
potentiation was virtually absent in NR1±1a/NR2A(H42G, dose±response curve with voltage-dependent block. To
distinguish between these two possibilities, we recordedH44S)/NR2B receptors (112% 6 2%, n 5 5). The results
support the premise that H42 and H44 of NR2A are also NMDA-evoked currents at different concentrations of Zn21
while ramping the voltage from 2100 to 150 mV in oo-involved in the inhibition caused by trace amounts of
Zn21 in more physiologically relevant heteromeric sub- cytes expressing NR1±1a/NR2A(H42G,H44S) receptors
(Figure 4C). The resulting I±V relationships revealed thatunit combinations. Although a mixture of NR1±1a/NR2A
and NR1±1a/NR2B receptors could have yielded similar a voltage-independent component of Zn21 inhibition
was still present in NR1±1a/NR2A(H42G,H44S) recep-results, this explanation appears less likely, given the
observation by Wafford et al. (1993) that after coinjection tors but occurred at .200-fold higher concentrations of
Zn21 compared with wild-type NR1±1a/NR2A receptors.of three NMDAR subunits into oocytes, the trihetero-
meric form of the receptor predominates. For concentrations of Zn21 $3 mM, outward rectification
became apparent. These results indicate that both volt-To demonstrate further that high-affinity Zn21 inhibi-
tion was indeed changed by H42 and/or H44 mutations, age-independent and voltage-dependent inhibition still
occurred in NR1±1a/NR2A(H42G,H44S) receptors, butwe constructed Zn21 dose±response curves for wild-
type and mutant NR1±1a/NR2A receptors (Figures 4A at similar Zn21 concentrations. Interestingly, in NR1±1a/
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Figure 4. Effect of NR2A(H42G,H44S) Muta-
tions on Zn21 Inhibition
(A) Representative current tracings from oo-
cytes expressing NR1±1a/NR2A(H42G,H44S)
receptors. Various concentrations of Zn21
were applied in the presence of saturating
concentrations of NMDA (200 mM) plus gly-
cine (100 mM). Zn21 concentrations #1 mM
correspond to free [Zn21] in solutions buf-
fered with 10 mM tricine (see Experimental
Procedures). Currents were recorded at a
holding potential of 240 mV at pH 7.3.
(B) Zn21 inhibition curves for wild-type NR1±
1a/NR2A (open circles), NR1±1a/NR2A(H42G)
(closed circles), NR1±1a/NR2A(H44S) (closed
squares), NR1±1a/NR2A(H42G,H44S) recep-
tors (open squares), and NR1±1a/NR2A(H42T,
H44D) receptors (closed triangles). NMDA-
evoked currents are expressed as a percent-
age of the current recorded in the presence
of the Zn21 chelator tricine (10 mM). Each
point represents the mean 6 SEM of the re-
sponses obtained from three to eight oo-
cytes.
(C) I±V relationship for an oocyte expressing
NR1±1a/NR2A(H42G,H44S) receptors at vari-
ous Zn21 concentrations. The ª0º Zn21 solution contained 10 mM tricine and was therefore nominally Zn21 free. Voltage-independent Zn21
inhibition was still present but of lower affinity compared with wild-type NR1±1a/NR2A receptors. At higher Zn21 concentrations ($3 mM), a
voltage-dependent component became evident. I±V curves were generated by continuously ramping the voltage, as described in the Experimen-
tal Procedures section. This experiment was repeated in seven oocytes with similar results.
(D) Zn21 inhibition curves for wild-type NR1±1a/NR2B (open circles), NR1±1a/NR2B(G43H,S45H) (closed squares), and NR1±1a/NR2B(T44H,D46H)
(open squares) receptors. NMDA-evoked currents are expressed as a percentage of the current recorded in the presence of the Zn21 chelator
tricine (10 mM) . Each point represents the mean 6 SEM of the responses obtained from three to four oocytes.
NR2B receptors, voltage-independent and voltage-depen- receptor properties, we constructed NMDA and glycine
dose±response curves for wild-type and mutant NR1±1a/dent inhibition occur at similar concentrations of Zn21,
and the dose±response curve of Zn21 inhibition for NR2A receptors (Figure 5). The EC50s for NMDA in NR1±
1a/NR2A(H42G,H44S) and NR1±1a/NR2A(H42T,H44D)NR1±1a/NR2B receptors can also be fit with a single
binding site isotherm with an IC50 value of 1.9 6 0.4 mM receptors were 60.1 6 1.6 mM and 59.7 6 1.2 mM, re-
spectively compared with 37.5 6 1.7 mM in wild-typeand Hill coefficient of 0.68 6 0.09 (Figure 4D). This value
is in good agreement with reported IC50s for NR1±1a/ NR1±1a/NR2A receptors. The EC50s for glycine in
NR1±1a/NR2A(H42G,H44S) and NR1±1a/NR2A(H42T,NR2B receptors ranging from 0.5 to 9.5 mM (Williams,
1996; Chen et al., 1997; Paoletti et al., 1997). Therefore, H44D) receptors were 1.6 6 0.1 mM and 2.3 6 0.1 mM,
respectively compared with 2.3 6 0.2 mM in wild-typethe NR2A(H42G,H44S) mutation produced NR2B-like
sensitivity to Zn21. NR1±1a/NR2A receptors. It appears, therefore, that the
agonist binding sites of the NMDA receptor are not muchNext, we introduced two histidine residues at the corre-
sponding positions of the NR2B subunit to see whether affected by these histidine mutations. Additionally, as
inferred from the Zn21 dose±response curves, voltage-we could produce high-affinity, voltage-independent Zn21
inhibition in NR1±1a/NR2B mutant receptors. However, dependent block by Zn21 did not appear to be changed
in NR1±1a/NR2A(H42G,H44S) receptors. The Q/N/R sitethe two knock-in mutants, NR2B(G43H,S45H) and NR2B
(T44H,D46H), behaved similarly to wild-type NR2B with in the M2 region, thought to represent the channel pore,
is a molecular determinant of voltage-dependent Zn21respect to Zn21 inhibition (for NR1±1a/NR2B, IC50 5 1.95 6
0.4 mM; for NR1±1a/NR2B(G43H,S45H), IC50 5 2.26 6 0.17 (Paoletti et al., 1997) and Mg21 block (Burnashev et al.,
1992; Mori et al., 1992; Sakurada et al., 1993). Thus, wemM; for NR1±1a/NR2B(T44H,D46H), IC50 5 1.05 6 0.15
mM) (Figure 4D). These data suggest that either (1) the conclude that the channel pore is little affected by these
histidine mutations.three-dimensional structure of NR2B is not capable of
producing high-affinity Zn21 coordination even with the
appropriate histidine residues, or (2) the two histidine
residues on NR2A are necessary but not sufficient for Mechanism of High-Affinity, Voltage-Independent
Zn21 Inhibition of NR1±1a/NR2A Receptors:high-affinity Zn21 inhibition; therefore, placing these his-
tidine residues in NR2B does not reproduce the high- Enhancement of Proton Inhibition?
Recently, it was suggested that Zn21 and proton inhibi-affinity Zn21 effect.
tion of NMDA receptors may share common structural
determinants based on the observation that mutationsEffect of Histidine Mutations on Other
NMDA Receptor Properties in amino acid residues on NR1±1a that change proton
inhibition also decreased the IC50 for voltage-indepen-To determine whether the mutation of histidine residues
produced extensive structural changes affecting NMDA dent Zn21 inhibition by 3- to 10-fold (Traynelis et al.,
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Figure 5. Agonist Dose±Response Curves
for Wild-Type and Mutant NR1±1a/NR2A Re-
ceptors
(A) NMDA dose±response curves in the pres-
ence of a saturating concentration of glycine
(100 mM).
(B) Glycine dose±response curves in the pres-
ence of a saturating concentration of NMDA
(200 mM). These curves were measured for
wild-type NR1±1a/NR2A (closed circles),
NR1±1a/NR2A(H42G,H44S) (open circles), and
NR1±1a/NR2A(H42T,H44D) (open squares) re-
ceptors. EC50 values were calculated from
dose±response curves generated by fitting
the data with the equation:
I 5 Imax/{1 1 (EC50/[agonist])n}
where n is the Hill slope and Imax is the maxi-
mum response normalized to 100%. Each
point represents the mean 6 SEM of the re-
sponses obtained from four to six oocytes.
1998). In a parallel manner, we tested whether H42 and sensors that directly mediate the pH effect. Most impor-
H44 mutations on NR2A would have an effect on proton tantly, the results show that the amount of free Zn21
inhibition of NMDAR responses. We found that mutating has a profound effect on proton inhibition of NMDAR
H42 and H44 shifted the IC50 for proton inhibition from responses. Along these lines, we found that proton inhi-
a pH of 7.33 to 6.89 in NR1±1a/NR2A receptors (Figure bition curves shifted to the left for both NR1±1a/NR2A
6A). This shift in IC50 could occur either because of a and NR1±1a/NR2B receptors as we raised the Zn21 con-
direct effect of histidine residues as proton sensors or centration in recording solutions (Figures 6B and 6C;
a secondary effect due to the removal of tonic Zn21 Table 1). In fact, the shift in IC50 for proton inhibition
inhibition. To distinguish between these two possibili- correlates with the percentage of inhibition caused by
ties, we performed experiments to construct proton inhi- a given Zn21 concentration rather than with the Zn21
bition curves in tricine-buffered (10 mM) solutions to concentration itself (Figure 6D). For example, the con-
remove endogenous Zn21. Under these conditions, the centration of Zn21 that contaminates standard recording
IC50 for proton inhibition was pH 6.97 for wild-type solutions (z100 nM) inhibits z55% of the NMDA-evoked
NR1±1a/NR2A receptors, a value similar to that of mu- current at 240 mV and pH 7.3, and this [Zn21] compared
tant NR1±1a/NR2A(H42T,H44D) receptors. In contrast, with the ª0º Zn21 concentration caused a shift of 0.35
for NR1±1a/NR2B receptors, the IC50 for proton inhibition pH units in the IC50 for proton inhibition of NR1±1a/NR2A
changed very little in tricine-buffered solutions (pH 7.48) responses (Figure 6D, left-hand side). In contrast, this
compared with normal recording solutions (pH 7.53). same 100 nM concentration of Zn21 produced only z5%
The Zn21 buffering capacity of tricine decreases as pH inhibition of NR1±1a/NR2B responses at 240 mV and
goes down, as noted by Paoletti et al. (1997). As a conse- pH 7.3 and a shift of only 0.05 pH units compared with
quence, at pH 6.0, a solution containing 10 mM tricine the ª0º Zn21 concentration (Figure 6D, right-hand side).
might not be nominally Zn21 free, as desired. However, at Therefore, one possible mechanism for voltage-inde-
pH 6.0, NMDA-evoked currents are already substantially pendent, high-affinity Zn21 inhibition involves enhance-
inhibited by protons, so that additional inhibition by
ment of proton sensitivity, i.e., there is greater proton
trace amounts of free Zn21 not buffered by tricine would
inhibition with greater degrees of Zn21 inhibition. How-
not substantially change the shape of the dose±response
ever, there may be other possible mechanisms of high-curve. Thus, we can draw the following conclusions.
affinity Zn21 inhibition as well. Interestingly, the shapeFirst, tricine itself has no intrinsic effect on proton inhibi-
of the proton inhibition curves at different Zn21 concen-tion, but it shifts the IC50 for proton inhibition of NR1±1a/
trations (Figures 6B and 6C) predicts that the magnitudeNR2A receptors by removing endogenous Zn21 from the
of inhibition by a fixed amount of Zn21 should be lesssolutions. Second, the two histidine residues them-
at a higher pH. This prediction is counterintuitive, be-selves (H42 and H44 of NR2A) have little direct effect on
cause at higher pH, there is increased ionization of theproton inhibition of NMDAR responses. Third, a subunit-
imidazole group on a histidine residue and thus facilita-specific difference for proton inhibition exists between
tion of Zn21 coordination; hence, voltage-independentNR1±1a/NR2A and NR1±1a/NR2B receptors, but it was
Zn21 inhibition should be greater. However, when inhibi-not apparent because of the tonic inhibition of NR1±1a/
tion by 1 mM Zn21 was tested at various pH values (6.5NR2A receptor responses by endogenous Zn21 that con-
to 8.5), the percentage of inhibition was the smallesttaminates recording solutions in the absence of chela-
at the highest pH for both NR1±1a/NR2A and NR1±1a/tion with tricine. Additionally, we found that treatment
NR2B receptors (Figures 6E and 6F). These results sug-with DEPC shifted the IC50 for proton inhibition further
gest that a possible mechanism of voltage-independentto the right, indicating that there are additional DEPC-
Zn21 inhibition of NMDAR responses is enhancement ofmodifiable histidines (other than NR2A[H42,H44]) or
other amino acid residues that may comprise the proton proton inhibition.
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Figure 6. Interactions between Proton and
Zn21 Inhibition of NMDAR Responses
(A) Proton inhibition curves of NMDA re-
sponses from wild-type NR1±1a/NR2A re-
ceptors in standard recording solution (open
circles), NR1±1a/NR2A receptors in ª0ª Zn21
tricine-buffered solution (closed circles),
NR1±1a/NR2A(H42T,H44D) receptors in stan-
dard solution (open squares), and NR1±1a/
NR2A receptors in standard solution after
DEPC treatment as in Figure 1 (closed trian-
gles). NMDA-evoked currents are expressed
as a percentage of the current recorded at a
high pH (.8.5). Each point represents the
mean 6 SEM of responses obtained from four
to eight oocytes.
(B and C) Proton inhibition curves of NMDA
responses from NR1±1a/NR2A (B) and NR1±
1a/NR2B (C) receptors at various Zn21 con-
centrations: ª0ª (closed circles), z100 nM
(open circles), 1 mM (open squares), and 10
mM (closed squares).
(D) Correlation between the shift in IC50 for
proton inhibition and the percent inhibition
by Zn21 of NMDA responses at various Zn21
concentrations. The number beside each data
point represents [Zn21] in the recording solu-
tion. Values for percentage of Zn21 inhibition
of NMDA responses were obtained from Fig-
ure 1C for NR1±1a/NR2A receptors and Fig-
ure 4D for NR1±1a/NR2B receptors.
(E) Representative current tracings from oo-
cytes expressing NR1±1a/NR2A (top) and
NR1±1a/NR2B (bottom) receptors. Inhibition
of currents by 1 mM Zn21 was measured at
various pH values in the presence of saturat-
ing concentrations of NMDA (200 mM) and
glycine (100 mM). Currents were recorded at
a holding potential of 280 mV.
(F) Summary of the pH dependency of inhibi-
tion of NMDA responses by 1 mM Zn21 for
NR1±1a/NR2A and NR1±1a/NR2B receptors.
Each point represents the mean 6 SEM of
NMDA-evoked currents obtained from four
oocytes.
Discussion of the coagonists NMDA and glycine or the voltage-
dependent effect of Zn21 in the channel pore. Second,
modifying histidine residues on wild-type NR1±1a/NR2AIn the present study, we have shown that mutating two
histidine residues (H42 and H44) in the putative extracel- receptors with DEPC also blocked the high-affinity, volt-
age-independent component of Zn21 inhibition, and thelular N terminus of NR2A markedly decreased the po-
tency of voltage-independent Zn21 inhibition of NR1±1a/ effect of DEPC could be partially blocked by coapplica-
tion of Zn21. These findings suggest that DEPC and Zn21NR2A receptors by z200-fold. X-ray crystallographic
analysis has revealed that the imidazole group of histi- compete for the same sites. Additionally, our data show
that mutating either histidine residue of the NR2A(H42,dine can interact directly with Zn21 (Vallee and Falchuk,
1993). Thus, H42 and H44 of NR2A may coordinate with H44) pair is sufficient to produce essentially the same
phenotype as mutating both, a common occurrence inZn21 and thus form a critical component of the Zn21
binding site on NR1±1a/NR2A receptors. Alternatively, it other Zn21 binding sites, as explained below. For the
known Zn21 binding sites of other proteins, the numberis possible that these histidine residues could influence
voltage-independent Zn21 inhibition without actually be- of residues between the first and second amino acid
ligands is nearly always one, two, or three, termed theing a part of the binding site. For example, mutating
histidine residues could cause conformational changes short spacer. The short spacer can form a bidentate
Zn21 complex that provides stability to the Zn21 bindingin the receptor±channel complex that disrupt the Zn21
binding sites, or they could modify the transduction site similar to a disulfide bond (Vallee and Falchuk, 1993).
The high affinity of NR1±1a/NR2A receptors for Zn21 ispathway through which Zn21 binding causes inhibition of
NMDA responses. However, for several reasons, these likely due to the presence of a short spacer (H42 and
H44 in this case), and mutations of the short spaceralternatives seem to be less likely than the hypothesis
that NR2A(H42,H44) coordinate with Zn21. First, mutat- would affect the stability of the Zn21 binding site. Mutat-
ing one histidine would disrupt this structure and woulding histidine residues did not unduly influence the effects
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responses may possibly be mediated by enhancementTable 1. IC50 and Hill Coefficients for Proton Inhibition of NR1-1a/
of proton inhibition. Recently, it was suggested that Zn21NR2A and NR1-1a/NR2B Receptors
and proton inhibition may share common structural de-
IC50 (pH) nH terminants (Traynelis et al., 1998), but heretofore, no
NR1±1a/NR2A ª0º Zn21 6.97 6 0.02 1.21 6 0.04 study had suggested that extracellular Zn21 can en-
NR1±1a/NR2A z100 nM Zn21 7.32 6 0.03 1.02 6 0.07 hance proton sensitivity. We found that the shift in IC50
NR1±1a/NR2A 1 mM Zn21 7.33 6 0.03 1.17 6 0.08 for proton inhibition correlates strongly with the percent-
NR1±1a/NR2A 10 mM Zn21 7.50 6 0.02 1.42 6 0.07
age of Zn21 inhibition caused by various concentrations
NR1±1a/NR2A post-DEPC 6.70 6 0.05 1.36 6 0.21 of Zn21 (Figure 6D). Furthermore, our data show that at
NR1±1a/NR2A(H42T,H44D) 6.89 6 0.04 1.28 6 0.14 high pH (low proton concentration), voltage-indepen-
NR1±1a/NR2B ª0º Zn21 7.48 6 0.02 1.30 6 0.08 dent Zn21 inhibition is greatly diminished. One potential
NR1±1a/NR2B z100 nM Zn21 7.53 6 0.02 1.30 6 0.08 concern with these experiments is that at high pH val-
NR1±1a/NR2B 1 mM Zn21 7.60 6 0.03 1.15 6 0.08 ues, there is an increase in the formation of hydroxide±
NR1±1a/NR2B 10 mM Zn21 7.80 6 0.04 1.31 6 0.13
Zn(II) complexes, which may precipitate out of solution.
NMDA-evoked currents were measured for NR1-1a/NR2A or NR1- However, the fraction of Zn21 participating in hydroxide±
1a/NR2B receptors expressed in oocytes. IC50 values 6 SD were Zn(II) complex formation is very small (see Experimental
calculated from dose±response curves generated by fitting the data Procedures) and cannot account for the decrease in
with the equation:
the Zn21 inhibition of NMDA-evoked responses that we
I 5 Imax/{1 1 ([H1]/IC50)n}, observed at high pH values. Additionally, our data dem-
onstrate that the degree of inhibition of NR1±1a/NR2Awhere n is the Hill slope and Imax is the current amplitude at pH 9.0.
receptors by protons at physiological pH may be far lessª0º Zn21 refers to solutions containing 10 mM tricine. A [Zn21] of
z100 nM is estimated to be the amount of Zn21 contaminating than previously thought, but this had gone unnoticed
standard recording solutions. Higher concentrations of Zn21 were because of the level of tonic inhibition caused by the
added to standard recording solutions in the absence of tricine. z100 nM [Zn21], which contaminates standard record-
ing solutions. Previous observations that any mutation
that shifted proton inhibition also shifted Zn21 inhibitionbe expected to cause Zn21 affinity to decrease dramati-
(Traynelis et al., 1998) would be readily explained by thecally, perhaps on the order of 100- to 1000-fold (Vallee
novel mechanism of Zn21 action that we suggest here ofand Falchuk, 1993). Thus, we believe that NR2A(H42,
extracellular Zn21 enhancing proton inhibition. However,H44) forms the predominant molecular determinant for
the converse is not true; mutation of NR1±1a(H42,H44)high-affinity Zn21 binding to NR1±1a/NR2A receptors.
shifted the IC50 for voltage-independent Zn21 inhibitionMutating NR2A(H42,H44) shifted the IC50 for voltage-
by z200-fold without having much effect on the IC50independent Zn21 inhibition z200-fold to the right, thus
for proton inhibition. Moreover, the link between protoneliminating the high-affinity component of Zn21 inhibi-
inhibition and voltage-independent Zn21 inhibition oftion, but it did not completely eliminate voltage-inde-
NMDA receptor activity is biologically relevant for bothpendent inhibition. This finding suggests that there are
physiological and pathophysiological reasons: first, dur-additional amino acid residues that contribute to the
ing neurotransmission, the NMDA component of the ex-site mediating voltage-independent Zn21 inhibition or
citatory postsynaptic potential may be modulated bythat there is more than one such site on NR1±1a/NR2A
concomitant changes in pH and [Zn21] that are knownreceptors. We prefer the first possibility for two reasons.
to occur at the synapse (Chesler and Kaila, 1992; SmartFirst, Zn21 is usually coordinated by four (or occasionally
et al., 1994), and second, during ischemia, acidificationsix) ligands, three of them being amino acid residues
inhibits NMDAR activity, and this potentially neuropro-and the fourth being H2O (Vallee and Falchuk, 1993).
tective event would be enhanced in the presence ofSecond, introducing histidine residues at the homolo-
Zn21 (Kaku et al., 1993; Koh et al., 1996).gous positions in NR2B failed to produce high-affinity
The relationship of high-affinity, voltage-independentZn21 inhibition of NR1±1a/NR2B receptor responses.
Zn21 inhibition and proton inhibition exemplifies anThus, additional ligands may be required to create the
emerging theme of the ªconvergenceº of modulatoryhigh-affinity Zn21 binding site, and the site may require
sites on the NMDA receptor. For example, the glycine-precise three-dimensional positioning of the two histi-
independent form of the spermine potentiation of NMDARsdine residues relative to the other ligands. Of note, mu-
lacking exon 5 in NR1 (i.e., NR1±1a) was reported to betating H42 and H44, which are unique to NR2A, lowered
due to relief from tonic proton inhibition (Traynelis etthe affinity for voltage-independent Zn21 inhibition of
al., 1995). Mutation of NR1±1a Cys-744 and Cys-798NR1±1a/NR2A receptor responses to a level very close
abolished not only dithiothreitol potentiation but alsoto that of wild-type NR1±1a/NR2B receptors (IC50 5 2.8
glycine-independent spermine potentiation and shiftedmM). Additional histidine or other amino acid residues
the sensitivity of NR1±1a/NR2B receptors to protonsthat are conserved between NR2A and NR2B may well
(Sullivan et al., 1994). Most recently, tyrosine kinase Src-be responsible for the remaining low-affinity, voltage-
induced potentiation was shown to be due to relief ofindependent inhibition of NR1±1a/NR2B and mutated
Zn21 inhibition (Zheng et al., 1998). Here, we provideNR1±1a/NR2A (H42G,H44S) receptors. Alternatively, the
a mechanistic link between proton inhibition and theunknown Zn21 ligand responsible for low-affinity, volt-
voltage-independent effects of Zn21 on the NMDA re-age-independent inhibition may reside on the NR1 sub-
ceptor. Considerable advances have been made in iden-unit (Hollmann et al., 1993).
tifying structural determinants of these modulators us-The results of the present study suggest that high-
affinity, voltage-independent Zn21
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mM KCl, 10 mM HEPES, 1.5 mM BaCl2, and 100 mM glycine (pHalso reveal the limitations of the site-directed mutagene-
7.5). Barium was used as the divalent cation, rather than calcium,sis approach in identifying structural determinants for
in order to minimize secondary activation of calcium-activated Cl2at least two reasons: first, several modulatory sites may
current (Leonard and Kelso, 1990). Drugs dissolved in frog Ringer
share common structural determinants, and second, as solution were applied by superfusion at a flow rate of z2 ml/min in
discussed by Traynelis et al. (1998), mutagenesis to re- an z100 ml chamber with an array of pipettes similar to the sewer
pipe system used in patch-clamp recording in order to achievemove the residues involved in binding of a modulator
relatively rapid solution exchange. Using a concentration jump para-may recruit neighboring residues to the binding site.
digm with Mg21, we measured a time constant of z3 s for completeTherefore, future crystallographic studies in conjunction
solution exchange in the recording chamber.with mutagenesis experiments will ultimately be re-
quired for complete elucidation of the mechanism of Zn21 Dose±Response Experiments
action of these modulators of NMDAR activity. Zn21 dose±response curves were generated by measuring steady-
state currents at 240 mV or during ramp protocols (47 mV/s from
2100 mV to 150 mV, and the leakage currents were subtracted)Experimental Procedures
after serial application of various concentrations of Zn21 in the pres-
ence of a saturating concentration of NMDA (200 mM) plus glycineSite-Directed Mutagenesis
(100 mM) at pH 7.3. As described in Paoletti et al. (1997), for [Zn21] #1Mutants were generated with the QuikChange site-directed muta-
mM, Zn21 solutions buffered with tricine (10 mM) were used becausegenesis kit using Pfu DNA polymerase and PCR (Stratagene, La
of the apparent high affinity of NR1±1a/NR2A receptors for Zn21.Jolla, CA). NMDA receptor subunit cDNA templates were pJS1 for
The solutions were prepared by adding 0.1, 0.3, 1.0, 3.0, 10.0, 29.3,NR1±1a, pJS2B for NR2B (gift from S. F. Heinemann, the Salk Insti-
and 91.7 mM of Zn21 to 10 mM tricine to yield estimated free Zn21tute, La Jolla, CA [Sullivan et al., 1994]), and NR2A (gift from P. H.
concentrations of 1, 3, 10, 30, 100, 300, and 1000 nM, respectively.Seeburg, Max Planck Institute for Medical Research, Heidelberg,
IC50 values 6 SD were calculated from dose±response curves gener-Germany [Monyer et al., 1992]). All experiments were performed
ated by fitting the data with a two binding site isotherm:with the NR1±1a splice variant that lacked exon 5 and contained
exons 21 and 22. This variant has been variously referred to as
y 5 1 2 {a/(1 1 IC50(1)/[Zn21]) 1 b/(1 1 IC50(2)/[Zn21])},NR1±1a (Hollmann et al., 1993), NR1001 (Durand et al., 1992), and
NR1A (Sugihara et al., 1992). Mutants were verified by sequencing where y is the relative current, a and b are the respective weights
through the mutant region, and the whole clones were verified by of each isotherm, a 1 b 5 1, and IC50(1) or IC50(2) is the concentration
restriction enzyme mapping generated with PstI to avoid duplica- producing 50% inhibition of each component for NR1±1a/NR2A re-
tions and deletions. NR1±1a constructs were cloned into the high- ceptors. Alternatively, if the dose±response curve for Zn21 inhibition
expression vector pGEMHE (Liman et al., 1992) to maximize the for a particular mutant receptor was well fit with a single binding
expression of NR1±1a receptor protein in Xenopus oocytes. site isotherm, we used the equation:
y 5 1 2 {1/(1 1 {IC50/[Zn21]}n)},cRNA Synthesis
The template was prepared from a circular plasmid cDNA by lineariz-
where y is the relative current, and n is the Hill coefficient. The extenting the 39 untranslated region with NheI (for NR1±1a), EcoRV (for
of formation of hydroxide(OH)±Zn(II) complex at high pH values wasNR2A), or BamHI (for NR2B). cRNA that incorporates the 59 cap
calculated with the equation (Martell and Smith, 1974; Traynelis etanalog (m7G(59)ppp(59)G) was transcribed from 1 mg of linearized
al., 1998):template in vitro by T7 (for NR1±1a and NR2B) or T3 (for NR2A)
RNA polymerase according to the mMessage mMachine protocol Zn21free/Zn21total 5 1/(1 1 [OH2]Ks1 1 [OH2]2Ks2 1
(Ambion, Austin, TX). cRNA concentrations were determined by [OH2]3Ks3 1 [OH2]4Ks4),
measuring the optical density at 260 nm and by agarose gel electro-
phoresis. where the log stability constants of ionization Ks(m) for Zn(OH)m122m
are 5.0 (for m 5 1), 11.1 (for m 5 2), 13.6 (for m 5 3), and 14.8 (for
m 5 4).Preparation of Oocytes and Injection of cRNA
As previously described (Hollmann et al., 1993; Sullivan et al., 1994),
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